Medical and Pharmaceutical Aerosols - Aerosols: Measurement, Dosimetry, and Health Effects - page 21

REFERENCES
1. Sciarra, J.J. and Cutie, A.J. Pharmaceutical aerosols. Drugs and the Pharmaceutical Sciences 40 ,
605-634 (1990).
2. Duke, J.A. Handbook of Edible Weeds . CRC: Boca Raton, FL (1992).
3. Thiel, C.G. From Susie's question to CFC free: An inventor's perspective on forty years of MDI devel-
opment and regulation. In: Dalby, R.N., Byron, P.R., and Farr, S.J., eds. Respiratory Drug Delivery V .
Interpharm Press: Buffalo Groove, IL, pp. 115-123 (1996).
4. Dunbar, C.A. and Hickey, A.J. A new millenium for inhaler technology. Pharmaceutical Technology 21 ,
116-125 (1997).
5. Crowder, T.M., Louey, M.D., Sethuraman, V.V., Smyth, H.D.C., and Hickey, A.J. 2001: An odyssey in
inhaler formulation and design. Pharmaceutical Technology 25 , 99-113 (2001).
6. Barnes, P.J. New concepts in chronic obstructive pulmonary disease. Annual Review of Medicine 54 ,
113-129 (2003).
7. Hillerdal, G. New principles for the treatment of diffuse pulmonary emphysema. Journal of Internal
Medicine 242 , 441-448 (1997).
8. Ding, J.Y. et al. Delivery of a chemotherapy agent for cancer treatment via nebulization. In: Dalby, R.N.
et al. eds. Respiratory Drug Delivery VIII . DHI: Tucson, AZ, pp. 359-362 (2002).
9. Patton, J.S., Bukar, J., and Nagarajan, S. Inhaled insulin. Advanced Drug Delivery Reviews 35 , 235-247
(1999).
10. Adjei, A. and Garren, J. Pulmonary delivery of peptide drugs: Effect of particle size on bioavailability of
leuprolide acetate in healthy male volunteers. Pharmaceutical Research 7 , 565-569 (1990).
11. Shukla, V.K. Tiotropium: A potential replacement for ipratropium in patients with COPD. Issues in
Emerging Health Technologies 35 , 1-4 (2002).
12. Sacchetti, M. and Van Oort, M.M. Spray-drying and supercritical luid particle generation techniques.
Inhalation Aerosols: Physical and Biological Basis for Therapy 94 , 337-384 (1996).
13. Crowder, T.M., Rosati, J.A., Schroeter, J.D., Hickey, A.J., and Martonen, T.B. Fundamental effects of
particle morphology on lung delivery: Predictions of Stokes' Law and the particular relevance to dry
powder inhaler formulation and development. Pharmaceutical Research 19 , 239-245 (2002).
14. Edwards, D.A. et al. Large porous particles for pulmonary drug delivery. Science 276 , 1868-1872
(1997).
15. Hickey, A.J. Delivery of drugs by the pulmonary route. Modern Pharmaceutics 121 , 479-500 (2002).
16. Hickey, A.J. Summary of common approaches to pharmaceutical aerosol administration. In: Hickey, A.J.,
ed. Pharmaceutical Inhalation Aerosol Technology . Marcel Dekker: New York, Vol. 54, pp. 255-288
(1992).
17. Cazzola, M., Segreti, A., and Matera, M.G. Novel bronchodilators in asthma. Current Opinion in
Pulmonary Medicine 16 , 6-12 (2010).
18. Tan, R.A. and Corren, J. Mometasone furoate in the management of asthma: A review. Therapeutics and
Clinical Risk Management 4 , 1201-1208 (2008).
19. Bousquet, J. Mometasone furoate: An effective anti-inlammatory with a well-deined safety and
tolerability proile in the treatment of asthma. International Journal of Clinical Practice 63 , 806-819
(2009).
20. Deeks, E. and Perry, C. Ciclesonide—A review of its use in the management of asthma. Drugs 68 ,
1741-1770 (2008).
21. Calverley, P. et al. One-year treatment with mometasone furoate in chronic obstructive pulmonary dis-
ease. Respiratory Research 9 , 73 (2008).
22. Carter, E. Letter from King Pharmaceuticals to Healthcare Professionals. (2009). At http://www.fda.gov/
downloads/Drugs/DrugSafety/DrugShortages/ucm089433.pdf
23. Geller, D.E. Aerosol antibiotics in cystic ibrosis. Respiratory Care 54 , 658-670 (2009).
24. O'Sullivan, B.P., Yasothan, U., and Kirkpatrick, P. Inhaled aztreonam. Nature Reviews Drug Discovery
9 , 357-358 (2010).
25. Elborn, J. and Henig, N. Optimal airway antimicrobial therapy for cystic ibrosis: The role of inhaled
aztreonam lysine. Expert Opinion on Pharmacotherapy 11 , 1373-1385 (2010).
26. Stribling, R., Brunette, E., Liggitt, D., Gaensler, K., and Debs, R. Aerosol gene delivery in vivo.
Proceedings of the National Academy of Sciences of the United States of America 89 , 11277-11281
(1992).